The effect of in vitro exposure to certain metformin doses on the motility of human spermatozoa.

Al-Nashme, Fatima Emad; Al-Jubory, Wasan Adnan

Metformin is an anti-hyperglycemic medication used to treat type 2 diabetes mellitus. Regardless of its anti-diabetic effect, metformin has a non-genomic action and it could be a beneficial additive to treat the sperm which considered as transcriptionally dormant cell and also a molecule that could rapidly adjust the metabolism of spermatozoa to adapt it to the surrounding environment. Sixty-four normozoospermic semen sample included in the study. Each sample incubated for 30 minutes with metformin (2.5 and 0.5 µM) and SFA was conducted to each sample. There was a significant decrease in total motility (progressive and nonprogressive) in samples incubated with both concentrations compared with the neat samples. While the samples incubated with 0.5 µM shows a lower motility compared with 2.5 µM. Metformin significantly reduced total motility of fresh spermatozoa at both concentrations.

TYPE 2 diabetes; SPERM motility; AMP-activated protein kinases; METFORMIN; SEMEN

Iraqi Journal of Embryos & Infertility Researches, 2022, Vol 12, Issue 1, p55

2218-0265

Academic Journal

10.28969/IJEIR.v12.i1.r5.22